Annual summary of publications

Publications (original articles or review articles) published in 2009 from OUS - Section of Cardiovascular and Renal Research

17 publications found

Aksnes TA, Kjeldsen SE, Schmieder RE (2009)
Hypertension and atrial fi brillation with emphasis on prevention
Blood Press, 18 (3), 94-8
DOI 10.1080/08037050903040744, PubMed 20499443

Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J (2009)
Time for new indications for statins?
Med Sci Monit, 15 (12), MS1-5
PubMed 19946240

de Simone G, Okin PM, Gerdts E, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Kjeldsen SE, Devereux RB (2009)
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study
Nutr Metab Cardiovasc Dis, 19 (9), 634-40
DOI 10.1016/j.numecd.2008.12.012, PubMed 19361968

Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2009)
Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
J Hum Hypertens, 24 (8), 505-13
DOI 10.1038/jhh.2009.94, PubMed 20010619

Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M (2009)
Long-term stability of cardiovascular and catecholamine responses to stress tests: an 18-year follow-up study
Hypertension, 55 (1), 131-6
DOI 10.1161/HYPERTENSIONAHA.109.143164, PubMed 19948985

Kjeldsen SE, Devereux RB, Hille DA, Lyle PA, Dahlöf B, Julius S, Edelman JM, Snapinn SM, de Faire U, Fyhrquist F, Ibsen H, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Blood Press, 18 (6), 348-61
DOI 10.3109/08037050903460590, PubMed 20001655

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Blood Press, 18 (6), 308-47
DOI 10.3109/08037050903450468, PubMed 20001654

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
J Hypertens, 27 (11), 2121-58
DOI 10.1097/HJH.0b013e328333146d, PubMed 19838131

Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, Dahlöf B, John M, Devereux RB, Okin PM (2009)
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study
Eur Heart J, 30 (23), 2908-14
DOI 10.1093/eurheartj/ehp321, PubMed 19687165

Okin PM, Devereux RB, Kjeldsen SE, Edelman JM, Dahlöf B (2009)
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study
J Hypertens, 27 (11), 2271-7
DOI 10.1097/HJH.0b013e328330b66b, PubMed 19834342

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators (2009)
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)
Circulation, 119 (14), 1883-91
DOI 10.1161/CIRCULATIONAHA.108.812313, PubMed 19332468

Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
J Hypertens, 27 (3), 567-74
DOI 10.1097/HJH.0b013e32831daf96, PubMed 19262226

Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J (2009)
Role and significance of statins in the treatment of hypertensive patients
Curr Med Res Opin, 25 (8), 1995-2005
DOI 10.1185/03007990903098081, PubMed 19555312

Tjugen TB, Flaa A, Kjeldsen SE (2009)
High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension
Prog Cardiovasc Dis, 52 (1), 20-5
DOI 10.1016/j.pcad.2009.05.008, PubMed 19615489

Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O (2009)
The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension
J Hypertens, 27 (4), 769-73
DOI 10.1097/HJH.0b013e328326f7eb, PubMed 19293724

Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM (2009)
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension
J Hypertens, 27 (4), 673-9
DOI 10.1097/HJH.0b013e3283298ea2, PubMed 19516168

Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE (2009)
Blood pressure control and components of the metabolic syndrome: the GOOD survey
Cardiovasc Diabetol, 8, 51
DOI 10.1186/1475-2840-8-51, PubMed 19754934

Publications Division of Medicine

Publications (original articles or review articles) published in 2009 from OUS - Section of Cardiovascular and Renal Research

17 publications found

Aksnes TA, Kjeldsen SE, Schmieder RE (2009)
Hypertension and atrial fi brillation with emphasis on prevention
Blood Press, 18 (3), 94-8
DOI 10.1080/08037050903040744, PubMed 20499443

Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J (2009)
Time for new indications for statins?
Med Sci Monit, 15 (12), MS1-5
PubMed 19946240

de Simone G, Okin PM, Gerdts E, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Kjeldsen SE, Devereux RB (2009)
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study
Nutr Metab Cardiovasc Dis, 19 (9), 634-40
DOI 10.1016/j.numecd.2008.12.012, PubMed 19361968

Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2009)
Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
J Hum Hypertens, 24 (8), 505-13
DOI 10.1038/jhh.2009.94, PubMed 20010619

Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M (2009)
Long-term stability of cardiovascular and catecholamine responses to stress tests: an 18-year follow-up study
Hypertension, 55 (1), 131-6
DOI 10.1161/HYPERTENSIONAHA.109.143164, PubMed 19948985

Kjeldsen SE, Devereux RB, Hille DA, Lyle PA, Dahlöf B, Julius S, Edelman JM, Snapinn SM, de Faire U, Fyhrquist F, Ibsen H, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Blood Press, 18 (6), 348-61
DOI 10.3109/08037050903460590, PubMed 20001655

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Blood Press, 18 (6), 308-47
DOI 10.3109/08037050903450468, PubMed 20001654

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
J Hypertens, 27 (11), 2121-58
DOI 10.1097/HJH.0b013e328333146d, PubMed 19838131

Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, Dahlöf B, John M, Devereux RB, Okin PM (2009)
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study
Eur Heart J, 30 (23), 2908-14
DOI 10.1093/eurheartj/ehp321, PubMed 19687165

Okin PM, Devereux RB, Kjeldsen SE, Edelman JM, Dahlöf B (2009)
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study
J Hypertens, 27 (11), 2271-7
DOI 10.1097/HJH.0b013e328330b66b, PubMed 19834342

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators (2009)
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)
Circulation, 119 (14), 1883-91
DOI 10.1161/CIRCULATIONAHA.108.812313, PubMed 19332468

Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
J Hypertens, 27 (3), 567-74
DOI 10.1097/HJH.0b013e32831daf96, PubMed 19262226

Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J (2009)
Role and significance of statins in the treatment of hypertensive patients
Curr Med Res Opin, 25 (8), 1995-2005
DOI 10.1185/03007990903098081, PubMed 19555312

Tjugen TB, Flaa A, Kjeldsen SE (2009)
High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension
Prog Cardiovasc Dis, 52 (1), 20-5
DOI 10.1016/j.pcad.2009.05.008, PubMed 19615489

Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O (2009)
The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension
J Hypertens, 27 (4), 769-73
DOI 10.1097/HJH.0b013e328326f7eb, PubMed 19293724

Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM (2009)
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension
J Hypertens, 27 (4), 673-9
DOI 10.1097/HJH.0b013e3283298ea2, PubMed 19516168

Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE (2009)
Blood pressure control and components of the metabolic syndrome: the GOOD survey
Cardiovasc Diabetol, 8, 51
DOI 10.1186/1475-2840-8-51, PubMed 19754934